“Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)” (2017) Swiss Medical Weekly, 147(3334), p. w14484. doi:10.4414/smw.2017.14484.